Multiple sclerosis: open trials in Estonia

• NCT07067463

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Clinic4U OÜ, Tallinn

  Registry updated 2026-11-03

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Clinic4U OÜ, Tallinn

  Registry updated 2026-10-27

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Tallinn · Novartis Investigative Site, Tartu

  Registry updated 2026-10-13

• 2024-511686-11-00

  Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Clinic4U OÜ, Tallinn

  Registry updated 2026-09-29

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Clinic4U OÜ, Tallinn · Tartu University Hospital, Tartu Linn

  Registry updated 2026-07-30

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error